1. PRESENTED BY: DR. HAMIDREZA NAJARI INFECTIOUS DISEASE SPECIALIST ASSISTED PROFESSOR OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES Diabetic foot.

Slides:



Advertisements
Similar presentations
Diabetic Foot Problems
Advertisements

Ventricular Assist Device Exit Site Care
Canadian Diabetes Association Clinical Practice Guidelines Foot Care
A Power Point Presentation By: Brody Nelson, EMT-P Student
Adult Medical-Surgical Nursing Endocrine Module: DM Footcare and Patient Teaching Plan.
Diabetic foot infection
Presented by Carl Norden, M.D. at the Anti-Infective Drugs Advisory Committee meeting on October 28, 2003.
Wound infection. Wound infection has a significant impact on economic and Patient outcomes (IWJ 2008), However it is often misdiagnosed and mistreated.
World Health Organization TB Case Definitions
THE DIABETIC FOOT DR.SEIF I M ELMAHI MD, FRCSI University of Khartoum, Sudan.
Best Practices for Pressure Ulcers to Promote Uncomplicated Healing.
Diagnostic Tests for Lower Extremity Osteomyelitis Laura Zakowski, MD* *no financial disclosures.
Pressure Ulcer Management By Susan Yap, PT. Anatomy of the Skin Epidermis Dermis Subcutaneous Tissue Fascia Muscle Tendon and Bone.
Slides current until 2008 Diabetic neuropathy Wound healing.
Ulcerations Due to Peripheral Vascular Disease
Lecture: Surgical Infection. Acute Purulent Infection of the Skin and Cellular Spaces. Reader: Kushnir R.Ya.
1. 2 Overview of diabetic foot infections Masood Ziaee,MD Des,11, 2008.
Necrotizing Fasciitis
Diabetic Foot Infection
Practical Guidelines for the Management of the Diabetic Foot Gerda van Rensburg PODIATRIST Area 556 Johannesburg Hospital.
Imaging Assessment of Diabetic Foot Infections Regina Alivisatos, MD Medical Officer DSPIDPs.
Drug Development for Diabetic Foot Infections: Lessons Learned
Calciphylaxis Induced Ulcerations. John M. Lavelle, 1 DO; Paul Liguori MD 2 1. Boston University Medical Center, Rehabilitation Department 2. Whittier.
VENOUS STASIS ULCERS. Venous stasis ulcer: occurs from chronic deep vein insufficiency and stasis of blood in the venous system of the legs An open, necrotic.
VISN 11 Wound Care Teleconsultation Program Julie Lowery, PhD Implementation Research Coordinator Leah Gillon, MSW Administrative Coordinator Diabetes.
M_MAHMOUDIEH General Surgeon Department of Surgery.
H.C.A TRAINING WOUND MANGEMENT Sally Panto Aug
Dr. Nancy Cornish Director of Microbiology Methodist and Children’s Hospitals CUTANEOUS INFECTIONS.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
Wound debridement Available methods for debridement Surgical Sharp Larval Enzymatic Autolytic Mechanical Chemical.
Wound Care Dr. Curtis Pedersen D.P.M.. What is Wound Care ?
AAWC Pressure Ulcer Guideline Content Validated, Evidence Based “Guideline of Pressure Ulcer Guidelines”
I NFECTIONS IN P ATIENTS WITH D IABETES P ART 3 OF 4 David Joffe, BSPharm, CDE Diabetes In Control Kelsey Schultz PharmD Candidate 2013 Butler University.
Plymouth Health Community NICE Guidance Implementation Group Workshop Two: Debriding agents and specialist wound care clinics. Pressure ulcer risk assessment.
Bone & Joints Infections. Osteomyelitis Osteomyelitis is infection of the bone. Infections can reach a bone by traveling through the bloodstream, spreading.
Osteomyelitis Dr. Belal Hijji, RN, PhD March 14, 2012.
Implications for clinical trials for diabetic foot infections (DFI) Anti-Infective Drugs Advisory Committee October 28, 2003 David Ross, M.D., Ph.D. Division.
Gas Gangrene A Presentation by Jennifer Kent-Baker.
Adult Medical-Surgical Nursing
Copyright © 2008 Delmar Learning. All rights reserved. Unit 6 Classification of Disease.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
What’s new in diabetes foot care? NICE and beyond Dr Simon Ashwell Consultant Diabetologist The James Cook University Hospital Middlesbrough.
Wound Care Chapter 5 Starts on page 100 Advanced Skills for Health Care Providers, Second Edition, Barbara Acello, 2007 Thompson Delmar.
A Clinician’s Approach to Treatment.  To understand the definition of cellulitis  To know what treatment is appropriate  To know when hospitalization.
Discussion.  Osteomyelitis is defined as an inflammation of the bone caused by an infecting organism  The infection may be limited to a single portion.
DR M A IDRIS. AIMS OF INVESTIGATION IN DMFS  Risk factors /Aetiology  Comorbidities  Complication(s)  Monitoring of treatment  Prognostication.
Diabetic Foot. DM largest cause of neuropathy. Foot ulcerations is most common cause of hospital admissions for Diabetics. Expensive to treat, may lead.
Cellulitis Darren Wilson Antibiotic Pharmacist Royal Bournemouth Hospital.
Diagnosis and treatment of DM foot infections (2012 IDSA Clinical Practice Guidelines) Moon Soo-youn Division of Infectious Diseases Kyung Hee University.
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
BONE AND JOINT INFECTION Dr.Syed Alam Zeb Orthopaedic Unit HMC.
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Musculoskeletal Disorders.
Assessment of the diabetic foot; how I assess
Antibiotic therapy in diabetic foot infection
By: Wajidah Abdul-Khabir PGY-2
GUIDELINES FOR PROSTHETIC JOINT INFECTION CID 2013
PRESURE ULCER Pressure ulcers cause pain, decrease quality of life, and lead to significant morbidity and prolonged hospital stays, in part due to complicating.
Osteomyelitis Stephanie Licano.
by Dr. Ammar Tlib Al-yassiri
Jennifer Koay, MD Assistant Professor Department of Radiology
DIABETIC FOOT CARE CARING FOR AND TREATING FOOT AND ANKLE CONDITIONS RELATED TO DIABETES.
Otitis Externa.
OBTAINING WOUND CULTURES
DEBRIDEMENT Professor Donald G. MacLellan Executive Director
Necrotising FASCIITIS
Infections in foot and ankle surgery – where are we now?
MODERATE Risk 1 RISK FACTOR PRESENT Deformity OR Neuropathy OR Peripheral arterial disease No other risk factors x6 more likely to ulcerate Annual assessment.
Éric Senneville, France (secretary)
Gerry Rayman Prashanth Vas Ketan Dhatariya Vicki Driver
Presentation transcript:

1

PRESENTED BY: DR. HAMIDREZA NAJARI INFECTIOUS DISEASE SPECIALIST ASSISTED PROFESSOR OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES Diabetic foot

Definition of DFIs Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration

Diabetic foot infections (DFIs) are a frequent clinical problem. Properly managed, most can be cured, but many patients needlessly undergo amputations because of improper diagnostic and therapeutic approaches

classic signs of inflammation (redness, warmth, swelling, tenderness, or pain) or purulent secretions, additional or secondary signs (eg, nonpurulent secretions, friable or discolored granulation tissue, undermining of wound edges, foul odor)

Risk factors probe-to-bone (PTB) test is positive an ulceration present for>30 days a history of recurrent foot ulcers a traumatic foot wound the presence of peripheral vascular disease in the affected limb a previous lower extremity amputation loss of protective sensation the presence of renal insufficiency A history of walking barefoot

assessment Clinicians should diagnose infection based on the presence of at least 2 classic symptoms or signs of inflammation They should then document and classify the severity of the infection based on its extent and depth The presence of any systemic findings of infection

assessment Clinicians should evaluate a diabetic patient presenting with a foot wound at 3 levels:  The patient as a whole  The affected foot or limb  The infected wound

assessment assessing the affected limb and foot for: arterial ischemia venous insufficiency presence of protective sensation biomechanical problems

For both outpatients and inpatients with a DFI, clinicians should attempt to provide a well- coordinated approach: those with expertise in a variety of specialties a multidisciplinary diabetic foot care team

Criteria for admission patients with a severe infection selected patients with a moderate infection with complicating features ( severe peripheral arterial disease or lack of home support) any patient unable to comply with the required outpatient treatment regimen for psychological or social reasons failing to improve with outpatient therapy

Criteria for discharge A patient with a DFI should be clinically stable; have had any urgently needed surgery performed; acceptable glycemic control be able to manage at the designated discharge location; have a welldefined plan that includes : an appropriate antibiotic regimen an off-loading scheme (if needed) specific wound care instructions Appropriate outpatient follow-up

Specimens for culture uninfected wounds: not collecting a specimen for culture For infected wounds: obtained specimens for culture prior to starting empiric antibiotic therapy. Cultures may be unnecessary for a mild infection in a patient who has not recently received antibiotic therapy sending a specimen for culture that is from deep tissue, obtained by biopsy or curettage after the wound has been cleansed and debrided. avoiding swab specimens, especially of inadequately debrided wounds

managment clinically uninfected wounds not be treated with antibiotic therapy prescribing antibiotic therapy for all infected wounds, with appropriate wound care

Threatment clinicians select an empiric antibiotic regimen on the basis of the severity of the infection and the likely etiologic agent(s) : a. For mild to moderate infections in patients who have not recently received antibiotic treatment, we suggest that therapy just targeting aerobic GPC is sufficient b. For most severe infections, we recommend starting broad-spectrum empiric antibiotic therapy, pending culture results and antibiotic susceptibility data

Threatment c. Empiric therapy directed at Pseudomonas aeruginosa is usually unnecessary except for patients with risk factors for true infection with this organism d. Consider providing empiric therapy directed against methicillin-resistant Staphylococcus aureus(MRSA): 1. in apatient with a prior history of MRSAinfection; 2. when the local prevalence of MRSA colonization or infection is high 3. if the infection is clinically severe

definitive therapy be based on the results of an appropriately obtained culture and sensitivity testing of a wound specimen as well as the patient’s clinical response to the empiric regimen

Route of therapy Route of therapy is based on infection severity:  parenteral therapy for all severe, and some moderate DFIs, at least initially, with a switch to oral agents when the patient is systemically well and culture results are available.  use highly bioavailable oral antibiotics alone in most mild, and in many moderate infections  topical therapy for selected mild superficial infections

Treatment It is suggested to continue antibiotic therapy until: resolution of findings of infection, but not through complete healing of the wound initial antibiotic course : for a soft tissue infection of about 1–2 weeks for mild infections 2–3 weeks for moderate to severe infections …

Imaging studeis all patients presenting with a new DFI have had plain radiographs of the affected foot to look for bony abnormalities (deformity, destruction) as well as for soft tissue gas and radio-opaque foreign bodies magnetic resonance imaging (MRI) as the study of choice for patients who require further imaging, particularly when soft tissue abscess is suspected or the diagnosis of osteomyelitis remains uncertain When MRI is unavailable or contraindicated, clinicians might consider the combination of a radionuclide bone scan and a labeled white blood cell scan as the best alternative

Osteomyelitis Clinicians should consider osteomyelitis as a potential complication of any infected, deep, or large foot ulcer, especially one that is chronic or overlies a bony prominence

Diagnosis of osteomylitis a PTB test for any DFI with an open wound. When properly conducted and interpreted, it can help to diagnose (when the likelihood is high) or exclude (when the likelihood is low) diabetic foot osteomyelitis (DFO). plain radiographs of the foot :serial plain radiographs to diagnose or monitor suspected DFO. MRI. If MRI is unavailable or contraindicated: leukocyte or antigranulocyte scan. the most definitive way to diagnose DFO is by the combined findings on bone culture and histology.When bone is debrided to treat osteomyelitis,we suggest sending a sample for culture and histology.

surgical intervention urgent surgical intervention for most foot infections accompanied by gas in the deeper tissues, an abscess, or necrotizing fasciitis, and less urgent surgery for wounds with substantial nonviable tissue or extensive bone or joint involvement. vascula surgery to consider revascularization whenever ischemia complicates a DFI. perform an urgently needed debridement or drainage

Wound care Appropriate wound care:  Debridement, aimed at removing debris, eschar, and surrounding callus  Sharp (or surgical) methods are generally best but mechanical, autolytic, or larval debridement techniques may be appropriate for some wounds  Redistribution of pressure off the wound to the entire weight-bearing surface of the foot (“off-loading”).

Adjunctive therapy The choice of dressing should be based on the size, depth, and nature of the ulcer (eg, dry, exudative, purulent) we do not advocate using topical antimicrobials for treating most clinically uninfected wounds. No adjunctive therapy has been proven to improve resolution of infection, but for selected diabetic foot wounds that are slow to heal, clinicians might consider using bioengineered skin equivalents, growth factors, granulocyte colony-stimulating factors,and hyperbaric oxygen therapy